I can understand holders feeling frustrated with delays and the like. Its been a torture holding this stock at times. A bottom draw stock.
At days end though they've done what most all other specs have failed to do, and that is raise $300 odd million without Dilution. That really does carry weight now we're moving to the near fully funded stage and into building a HPSM plant.
Add that the announcement of Resource upgrade due this or next week is directly linked to Support from NAIF for the Stage 2 development, once again Dilutive free.
Love him or hate him, he's done a tremendous effort in raising cash without generating shares.
Its now firmly out of the bottom draw.
Here hoping we hear more news on the Nissan deal and the Patent being granted.
- Forums
- ASX - By Stock
- E25
- Ann: E25 HPMSM project selected for US$166M DoE Grant
E25
element 25 limited
Add to My Watchlist
7.14%
!
22.5¢

Ann: E25 HPMSM project selected for US$166M DoE Grant, page-48
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
22.5¢ |
Change
0.015(7.14%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 21.5¢ | $36.91K | 166.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11163 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 101483 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2217 | 0.225 |
1 | 11163 | 0.220 |
4 | 46976 | 0.215 |
2 | 5119 | 0.210 |
3 | 338235 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 101483 | 3 |
0.230 | 72958 | 1 |
0.235 | 124800 | 3 |
0.240 | 255584 | 3 |
0.245 | 21276 | 1 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online